investment-strategies

Image for Oil surges 5% after US sanctions Russian firms Rosneft, LukoilFinance

Oil Surges 5% After US Sanctions Russian Firms Rosneft, Lukoil

Image for Analysis-From FOMO to fear of margin calls: gold's wild ride enters new stageFinance

Analysis-From Fomo to Fear of Margin Calls: Gold's Wild Ride Enters New Stage

Image for Trading Day: Stocks' momentum fades, gold plungesHeadlines

Trading Day: Stocks' Momentum Fades, Gold Plunges

Image for Oil settles higher as investors focus on supply signalsFinance

Oil Settles Higher as Investors Focus on Supply Signals

Image for Regionals spoil the banking party

Regionals Spoil the Banking Party

Date: October 16, 2025

By Alden Bentley NEW YORK (Reuters) -Making sense of the forces driving global marketsBy Alden Bentley, Editor in Charge, Americas Finance and Markets        Jamie is enjoying some well-deserved time-...

Image for BBVA fails in $19 billion takeover battle for Sabadell

BBVA Fails in $19 Billion Takeover Battle for Sabadell

Date: October 16, 2025

By Jesús Aguado MADRID (Reuters) -Spain's BBVA said on Thursday its hostile takeover bid for smaller rival Sabadell failed as it could not secure at least 30% of its shares in a public tender offer...

Image for US stocks pulled lower by financials; gold hits record highs

US Stocks Pulled Lower by Financials; Gold Hits Record Highs

Date: October 16, 2025

By Kevin Buckland TOKYO (Reuters) -Stocks rose across most of Asia on Thursday, with the chip sector buoyant following a strong rally among U.S. peers overnight. A robust start to the earnings season...

Image for Goldman Sachs expects copper price to remain in $10,000-$11,000/t price range in 2026/2027

Goldman Sachs Expects Copper Price to Remain in $10,000-$11,000/t Price Range in 2026/2027

Date: October 10, 2025

(Reuters) -Copper prices are expected to stay in a range of $10,000-$11,000 per metric ton in 2026/2027 due to a market surplus, though the long-term outlook remains positive, Goldman Sachs said in a...

Image for Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

Next Medicine Deal After Pfizer? Analysts, Shares Point to AstraZeneca, Eli Lilly

Date: October 10, 2025

By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with...

Image for Analysis-Gold's record run creates new rulebooks for investors

Analysis-Gold's Record Run Creates New Rulebooks for Investors

Date: October 10, 2025

By Lucy Raitano, Naomi Rovnick and Amanda Cooper LONDON (Reuters) -Investors are testing well-established views about gold, which is surging to new records, as an AI-driven stocks rally and red-hot...